Prime-boost strategies for malaria vaccine development.

Prime-boost strategies for malaria vaccine development.

Malaria is an intracellular pathogen, for which an effective vaccine is likely to require induction of cell-mediated immunity. Immunisation approaches that stimulate strong and persistent levels of effector T-cells are being sought by many researchers. DNA vaccines, recombinant protein and viral vec...

Bibliografske podrobnosti
Main Authors:	Dunachie, S, Hill, A
Format:	Journal article
Jezik:	English
Izdano:	2003

Podobne knjige/članki

Prime-boost vectored malaria vaccines: progress and prospects.
od: Hill, A, et al.
Izdano: (2010)

DNA-based vaccines for malaria: a heterologous prime-boost immunisation strategy.
od: Hill, A, et al.
Izdano: (2000)

Progress in DNA-based heterologous prime-boost immunization strategies for malaria.
od: Moore, A, et al.
Izdano: (2004)

Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis.
od: Gilbert, S, et al.
Izdano: (2006)

Complete protective immunity against blood-stage malaria induced by heterologous prime-boost vaccination
od: Draper, S, et al.
Izdano: (2005)

Prime-boost immunisation strategies for tuberculosis.
od: Mcshane, H, et al.
Izdano: (2005)

Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers.
od: Vuola, J, et al.
Izdano: (2005)

A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS.
od: Dunachie, S, et al.
Izdano: (2006)

Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M
od: Venkatraman, N, et al.
Izdano: (2017)

Developing a personalized heterologous prime boost vaccination strategy for tumor therapy
od: Ramirez-Valdez, RA
Izdano: (2021)

Novel prime-boost vaccine strategies against HIV-1
od: Jean-Louis Excler, et al.
Izdano: (2019-08-01)

Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria.
od: Keating, S, et al.
Izdano: (2005)

Sterile protection against Plasmodium knowlesi in rhesus monkeys from a malaria vaccine: comparison of heterologous prime boost strategies.
od: George Jiang, et al.
Izdano: (2009-08-01)

Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian men.
od: Moorthy, V, et al.
Izdano: (2004)

Heterologous Prime-boost COVID-19 Vaccination
od: Vishal R. Tandon, et al.
Izdano: (2021-10-01)

Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines.
od: Hanke, T
Izdano: (2014)

Prime-boost AIDS Vaccine Strategies Based on Replication-Competent Adenovirus Recombinants
od: Srivastava Indresh, et al.
Izdano: (2005-12-01)

Heterologous Prime-Boost Vaccination with Commercial FMD Vaccines Elicits a Broader Immune Response than Homologous Prime-Boost Vaccination in Pigs
od: Jaejo Kim, et al.
Izdano: (2023-02-01)

Evaluation of prime boosting vaccination strategy using newly constructed tuberculosis vaccine candidates in mice
od: Zakaria, Nurazwana
Izdano: (2013)

Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques.
od: Rogers, W, et al.
Izdano: (2001)

Efficient homologous prime-boost strategies for T cell vaccination based on virus-like particles.
od: Schwarz, K, et al.
Izdano: (2005)

Immunogenicity and persistence of a prime-boost re-vaccination strategy for pneumococcal vaccines in patients with rheumatoid arthritis
od: Mathilde Bahuaud, et al.
Izdano: (2018-06-01)

Optimize Prime/Boost Vaccine Strategies: Trained Immunity as a New Player in the Game
od: Jean-Louis Palgen, et al.
Izdano: (2021-03-01)

Prime-boost immunization strategies for infectious diseases.
od: Mcshane, H
Izdano: (2002)

A three-antigen Plasmodium falciparum DNA prime—Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults
od: Sklar, MJ, et al.
Izdano: (2021)

Induction of CD8+ T cells using heterologous prime-boost immunisation strategies.
od: Schneider, J, et al.
Izdano: (1999)

Different immunogens and prime-boost vaccination strategies affect the efficacy of recombinant candidate vaccines against pathogenic orthopoxviruses
od: Antonia Radaelli, et al.
Izdano: (2024-11-01)

Modeling the Dependence of Immunodominance on T Cell Dynamics in Prime-Boost Vaccines
od: Clemente Fernandez Arias, et al.
Izdano: (2020-12-01)

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes.
od: Gilbert, S, et al.
Izdano: (2002)

Immunogenicity study of dna vaccine and dna vaccine carrier expressing vp1 of enterovirus 71 in the prime boost vaccination strategy
od: Nur Ayuni, Kadir
Izdano: (2008)

Therapeutic vaccination against hepatitis B virus using heterolgous prime boost strategy with DNA and modified vaccinia virus ankara vectors
od: McConkey, S, et al.
Izdano: (2003)

P19-58 LB. Comparison of the immunogenicity in humans and rhesus macaques of vaccines consisting of DNA priming and MVA boosting and MVA priming and boosting
od: Wyatt LS, et al.
Izdano: (2009-10-01)

Malaria vaccine developments.
od: Moorthy, V, et al.
Izdano: (2004)

A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activity.
od: Goodman, A, et al.
Izdano: (2011)

Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
od: Shaw, RH, et al.
Izdano: (2021)

Statistical considerations for the platform trial in COVID-19 vaccine priming and boosting
od: Michael Dymock, et al.
Izdano: (2024-07-01)

Heterologous prime-boost vaccination against COVID-19: is it safe and reliable?
od: Om Prakash Choudhary, et al.
Izdano: (2021-12-01)

A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge.
od: Dunachie, S, et al.
Izdano: (2006)

MIG and the regulatory cytokines IL-10 and TGF-[beta]1 correlate with malaria vaccine immunogenicity and efficacy.
od: Dunachie, S, et al.
Izdano: (2010)

MIG and the regulatory cytokines IL-10 and TGF-β1 correlate with malaria vaccine immunogenicity and efficacy
od: Dunachie, S, et al.
Izdano: (2010)